Are you Dr. Matthay?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 63 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-3831Fax+1 415-502-4372- Is this information wrong?
Summary
- Dr. Katherine Matthay, MD is a hematologist in San Francisco, California. She is currently licensed to practice medicine in California and Colorado. She is affiliated with UCSF Medical Center and John Muir Medical Center, Walnut Creek.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 1977 - 1978
University of ColoradoResidency, Pediatrics, 1973 - 1976
Perelman School of Medicine at the University of PennsylvaniaClass of 1973
Certifications & Licensure
CA State Medical License 1977 - 2025
CO State Medical License 1975 - 1983- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- N99-02: Melphalan and Buthionine Sulfoximine Start of enrollment: 2001 Aug 01
- N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma Start of enrollment: 2000 May 01
- N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.Prerna Kumar, Victoria W Willard, Leanne Embry, Arlene Naranjo, Brian LaBarre, Katherine K Matthay, Pedro A de Alarcon> ;Pediatric Blood & Cancer. 2024 Apr 30
- Pediatric neuroblastoma with intraspinal extension: the role of surgical management.Edwards, C., Oh, T., Roland, J., Matthay, K., Vo, K., Sun, P., Auguste, K., Gupta, N., Chang, D.> ;Journal of Neurosurgery. Pediatrics. 2024 Mar 1
- Modulation of Radiation Biomarkers in a Randomized Phase II Study ofI-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma.Kevin Campbell, Susan Groshen, Angela C Evans, Stephen Wilson, Aimy Sebastian, Gabriela G Loots, Araz Marachelian, Myriam Armant, Sharmistha Pal, Daphne A Haas-Kogan, ...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Apr 1
- Join now to see all
Grant Support
- Pediatric Malignancies ProgramNational Cancer Institute2007–2011
- Clinical Therapy TrialsNational Cancer Institute2000–2011
- NANT 2003-01: Phase I Study Of Oral Irinotecan, Temozolomide, And CefiximeNational Center For Research Resources2005
- NANT #9902: Modulation Of L-PAM By BSO With Autologous Stem Cell SupportNational Center For Research Resources2005
- Impact Of Body Composition On PK Of Doxorubin In Pediatric PatientsNational Center For Research Resources2005
- Dose Escalation Study Of 131 I-MIBG With Chemotherapy And Stem Cell RescueNational Center For Research Resources2005
- Anbl02p1: A Pilot Induction Regimen Incorporating Topotecan For NeuroblastomaNational Center For Research Resources2005
- NANT 2001-03: Phase I Study Of CEP-701 In Patients With Refractory NeuroblastomaNational Center For Research Resources2004–2005
- NANT 2001-01:A Phase I Investigation Of Il-12/Pulse IL-2 In ChildrenNational Center For Research Resources2004–2005
- 131 I-MIBG Double Infusion Followed By Stem Cells For Refractory NeuroblastomaNational Center For Research Resources2004–2005
- 131 I-Labeled MIBG For Treatment Of Advanced Neuroblastoma: A Phase II StudyNational Center For Research Resources2004–2005
- Phase I Intergroup Trial Of Hu14.18-Il.2 Fusion Protein In ChildrenNational Center For Research Resources2004
- Nant2002-01: A Phase I Study Of High Dose PyrazoloacridineNational Center For Research Resources2004
- Impact Of Body Composition On PK Of Doxorubicin In PedNational Center For Research Resources2004
- Advl0116: A Phase I Trial And PK Study Of R115777 In Pediatric PatientsNational Center For Research Resources2004
- 131 I-MIBG Escalating Dose Rapid Sequence Double Infusi*National Cancer Institute2004
- 131imibg Escalating Dose Rapid Sequence Double InfusionNational Cancer Institute2003
- CCG 09709: Fenretinide In Children W/ High Risk Solid TumorsNational Center For Research Resources2000–2002
- CCG 0954: Gemcitabine In Solid TumorsNational Center For Research Resources2000–2002
- Trial Of Temozolomide In Children And Adolescents With Progressive CancerNational Center For Research Resources1998–2002
- Phase I Study Of Gamma Interferon Transduced Neuroblastoma CellsNational Center For Research Resources1998–2002
- Phase I Study Of D1694 In Pediatric Patients With Advanced Neoplastic DiseaseNational Center For Research Resources1998–2002
- Phase I Study Of Continuous 21 Day Topotecan In Children With Relapsed TumorsNational Center For Research Resources1998–2002
- Phase I Study Of Anti B4 Blocked Ricin In Children With Leukemia Or LymphomaNational Center For Research Resources1998–2002
- Pediatric Trial And PK Study Of Lgd1057National Center For Research Resources1998–2002
- CI Mercaptopurine Followed By CI ARA-C In ChildrenNational Center For Research Resources1998–2002
- B43-PAP Immunotoxin With 4 Drug Induction For All In RelapseNational Center For Research Resources1998–2002
- Pilot Study Of Buthionine Sulfoximine In Combination With MelphalanNational Center For Research Resources1997–2002
- I-131 MIBG Therapy For NeuroblastomaNational Center For Research Resources1997–2002
- Phase I Study Of Taxotere In Pediatric Patients With Advanced Neoplastic DiseaseNational Center For Research Resources1996–2002
- Phase I Chimeric Human/Murine Anti-Gd2 Monoclonal Antibody With GM-CSFNational Center For Research Resources1996–2002
- Childrens Cancer GroupNational Cancer Institute1994–2002
- Thrombopoietin &G-Csf In Child Solid TumorsNational Center For Research Resources2000
- Paclitaxel In Refractory Leukemia In ChildrenNational Center For Research Resources2000
- Phase I Study Of Topotecan And Field Radiation For Pontine Glioma Of ChildhoodNational Center For Research Resources1998–1999
- Phase I Study Of Topotecan And Cisplatin In Solid Tumors In ChildrenNational Center For Research Resources1998–1999
- Phase I Multiple Cycles Of High Dose Chemotherapy With Stem Cell TransfusionsNational Center For Research Resources1998–1999
- IL 6 PLUS G-CSF Following ICE In Children With Recurrent Solid TumorsNational Center For Research Resources1998–1999
- Phase I Study Of Taxol In Refractory Leukemia In ChildrenNational Center For Research Resources1997
- Phase I Trial Of Temozolomide In Children &Adolescents With Progressive CancerNational Center For Research Resources1996
- I-131 MIBG For Treatment Of Advanced NeuroblastomaNational Center For Research Resources1995–1996
- Treatment Of Newly Diagnosed Acute Lymphoblastic Leukemia In ChildrenNational Center For Research Resources1995
- Phase I Trial Of All-Trans Retinoic Acid In Combination With InterferonNational Center For Research Resources1995
- Phase I Evaluation Of Oral/Intravenous Navelbine In Pediatric Cancer PatientsNational Center For Research Resources1995
- Chemotherapy VS Autologous Bone Marrow Transplant For High Risk NeuroblastomaNational Center For Research Resources1995
- Children'S Cancer Study GroupNational Cancer Institute1993
- Treatment Of Leukemia By Antibody-Directed LiposomesNational Cancer Institute1989–1991
- Treatment Of Bone Marrow By Antibody-Directed LiposomesNational Cancer Institute1985–1987
Professional Memberships
- Member
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
John Muir Medical Center, Walnut CreekWalnut Creek, California
